Shilpa Pharma, Inc.

Shilpa Pharma, Inc. company information, Employees & Contact Information

Shilpa Pharma, Inc. is the US operating company of Shilpa Medicare Limited, one of the largest specialty generic pharmaceutical companies in the world. Based in India, they have API and finished formulation production facilities while providing high-quality, affordable medicines trusted by healthcare professionals and patients in over 100 countries globally. Shilpa Medicare Limited is establishing collaborations including in/out-licensing of products and technologies, strategic alliances, joint ventures, and mergers and acquisitions as they strengthen their presence in other markets across the world. Shilpa Pharma, Inc. will develop and support these collaborations here in the US. To learn more, please visit vbshilpa.com.

Company Details

Employees
247
Founded
-
Address
668 Us-206,
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Hillsborough, New Jersey
Looking for a particular Shilpa Pharma, Inc. employee's phone or email?

Shilpa Pharma, Inc. Questions

News

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma - Yahoo Finance

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma Yahoo Finance

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics - TheWire.in

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics TheWire.in

Shilpa Medicares NorUDCA Makes History as First Approved NAFLD Therapy Worldwide - Tribune India

Shilpa Medicares NorUDCA Makes History as First Approved NAFLD Therapy Worldwide Tribune India

Shilpa Medicare Makes History: First Indian Company Completes Phase 1 Trial for Recombinant Human Albumin (rHA) 20 per cent - ThePrint

Shilpa Medicare Makes History: First Indian Company Completes Phase 1 Trial for Recombinant Human Albumin (rHA) 20 per cent ThePrint

Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH - ANI News

Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH ANI News

Top Shilpa Pharma, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant